Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
Can iShares MSCI Israel ETF (EIS) Deliver a +12.5% Advance to $135?

Can iShares MSCI Israel ETF (EIS) Deliver a +12.5% Advance to $135?

Key Takeaways

  • The iShares MSCI Israel ETF (EIS) tracks the MSCI Israel Capped Investable Market Index and is not an individual stock.
  • The $135 level is a technical objective drawn from the fund’s prior 52-week high near $138 and resistance zones noted in market commentary, rather than an analyst consensus target.
  • With a recent price near $120, a move to $135 would represent an advance of roughly 12.5%, a meaningful gain for a single-country ETF.
  • Support comes from Israel’s technology and financials exposure, easing inflation, and economic normalization, while geopolitical risk and sector concentration remain the primary concerns.
  • No meaningful sell-side consensus exists for EIS, so investors rely on valuation, technical levels, and the outlook for underlying holdings.
  • Additional details are available on the fund’s Major News, Today’s Price Move, Forecast, and Earnings pages.

Setting the $135 Technical Target

EIS is an ETF, so it lacks the sell-side analyst price-target consensus typical of individual stocks. MarketBeat shows no independently meaningful consensus for the fund itself. The $135 objective instead stems from public market discussion and technical research. The fund reached a 52-week high near $138 within a range of roughly $98 to $138, and independent commentary has highlighted resistance and profit-target zones between about $131 and $141. A round-number goal of $135 falls comfortably inside that band and remains both unachieved and realistically attainable from current levels.

EIS’s Current Position and Path Forward

As of late October 2026, EIS traded near $120, with net asset value in a similar range. Reaching $135 would require an advance of approximately 12.5%, a substantial move for a concentrated single-country fund. The route would likely pass through the fund’s holdings, weighted roughly 36% to financials, 20% to information technology, 12% to health care, and about 10% to industrials, with smaller allocations to real estate and utilities. Because Israeli banks and technology companies dominate, progress toward $135 hinges on sustained earnings growth in those areas, continued disinflation, and stable investor sentiment toward Israeli equities.

Factors That Could Drive EIS Higher

Several elements could support a recovery toward $135. Israel’s economy has seen strong GDP growth forecasts and easing inflation, which benefits the banking-heavy portfolio through net interest income and loan growth. The technology allocation offers exposure to software and cybersecurity names with durable demand, while defense and industrials segments have gained from rising regional security spending. The fund’s trailing price-to-earnings ratio of roughly 18x appears reasonable for a growth-oriented, technology-skewed basket, and the index’s capping methodology, which limits any single group entity to 25%, helps manage concentration risk. Renewed inflows into single-country Israel exposure would provide additional support.

Risks That Might Hold EIS Back

The main obstacle remains geopolitical risk. Escalating regional conflict has historically triggered sharp drawdowns in Israeli equities, compressing valuations and prompting outflows. The portfolio is also heavily concentrated, with financials alone accounting for more than a third of assets, so bank-specific weakness or rate cuts that pressure net interest margins would weigh disproportionately. Sector concentration in technology adds valuation sensitivity to rising interest rates, while the fund’s 0.59% expense ratio and limited liquidity compared with broad-market ETFs can increase trading costs. A global risk-off environment or rotation away from international and emerging-market equities could further delay any approach to $135.

Key Technical Levels and Market Structure

EIS has traded in a broad 52-week range from roughly $98 to $138, and the $138 area stands as the most important overhead resistance—a level the fund tested but has not sustained above. Below the recent price, support has formed near $116 to $118, with a secondary zone in the low $120s. The round-number $130 level represents a psychological milestone on the way to $135. A durable close above $130 would suggest renewed momentum, while a failure to hold above $118 would indicate that the longer-term uptrend is weakening.

Investment Horizon and Metrics to Monitor

Because the $135 objective is technical rather than analyst-derived, it carries no formal 12-month research horizon; targets of this kind are typically evaluated over weeks to a year depending on conditions. Investors should watch Israeli inflation and central-bank rate decisions, quarterly earnings from the fund’s largest bank and technology holdings, fund flows and AUM changes, the shekel-dollar exchange rate, and any escalation or de-escalation in regional geopolitics. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers in similar single-country categories. Revisions in the broader emerging-market and single-country equity outlook are worth tracking as well.

Final Assessment

The question of whether the iShares MSCI Israel ETF can reach $135 is, in effect, a question about Israeli equities broadly. The target reflects a technical objective drawn from the fund’s prior high near $138 and publicly discussed resistance zones, not a published analyst consensus. Achieving it would require a substantial move of roughly 12.5%, supported by easing inflation, resilient banking and technology earnings, and renewed investor inflows. Against that, geopolitical uncertainty, heavy financials concentration, and rate-driven valuation pressure on technology names remain meaningful obstacles. With no reliable analyst price-target aggregate for EIS itself, investors should weigh the fund’s valuation, sector composition, and technical levels alongside developments in Israel’s economy and security environment before drawing conclusions.

Leveraging Tickeron’s AI Daily Buy/Sell Signals

In my own work with single-country ETFs like EIS, I regularly consult Tickeron’s AI Daily Buy/Sell Signals. The platform applies artificial intelligence to monitor thousands of securities and generate Buy, Sell, or Hold signals as market conditions and technical behavior evolve. It helps surface opportunities and track momentum shifts more efficiently than manual review alone, which is especially useful for instruments influenced by macro data and geopolitics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EIS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


EIS's RSI Oscillator recovers from oversold territory

The RSI Oscillator for EIS moved out of oversold territory on October 13, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +3.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where EIS advanced for three days, in 306 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

EIS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EIS as a result. In 74 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for EIS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 41 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

EIS moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EIS crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

The 50-day moving average for EIS moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EIS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for EIS entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Industry description

The investment seeks to track the investment results of the MSCI Israel Capped Investable Market Index (IMI). The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index rhat is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Israel. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares MSCI Israel ETF (EIS) ETF is 7.11B. The market cap for tickers in the group ranges from 752.77M to 49.09B. TEVA holds the highest valuation in this group at 49.09B. The lowest valued company is KRNT at 752.77M.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI Israel ETF (EIS) ETF was -4%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -12%. RDWR experienced the highest price growth at 11%, while MNDY experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI Israel ETF (EIS) ETF was 49%. For the same stocks of the ETF, the average monthly volume growth was 19% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 42
Price Growth Rating: 49
SMR Rating: 72
Profit Risk Rating: 76
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
EIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Unknown

Category
Focused Region
Address
iShares, Inc.400 Howard StreetSan Francisco
Phone
N/A
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.